Charming Medical Limited (MCTA)

Charming Medical Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023
Net Income	0.91	0.78	-0.31
Depreciation & Amortization	0.36	0.39	0.21
Other Operating Activities	-1.09	-0.92	2.56
Operating Cash Flow	0.19	0.3	2.43
Operating Cash Flow Growth	-	-87.86%	-
Capital Expenditures	-0.17	-0.21	-0.61
Investing Cash Flow	-0.17	-0.21	-0.61
Debt Issued / Paid	-	0.13	-1.43
Other Financing Activities	1.54	-0.03	-
Financing Cash Flow	1.54	0.1	-1.43
Net Cash Flow	1.55	0.18	0.4
Free Cash Flow	0.01	0.08	1.83
Free Cash Flow Growth	-	-95.36%	-
Free Cash Flow Margin	0.16%	1.41%	51.76%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).